Is Merck stock really cheap? Merck & Co., Inc. (NYSE:MRK) is guiding for adjusted EPS between $3.45 and $3.55. At the midpoint, its P/E is 13.5.

Merck & Co., Inc. (NYSE:MRK) also announced today that it would be buying back additional shares. The company plans to spend $5 billion on almost 100 million shares that Goldman Sachs owns.

Merck & Co., Inc. (NYSE:MRK) was in 56 hedge funds' portfolio at the end of March. MRK investors should pay attention to a decrease in hedge fund sentiment of late.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S.

Medtronic, Inc. (NYSE:MDT) There's hardly any certainty in the market, but even I have to admit it's become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight sessions while the broad-based S&P 500 ...

Merck & Co., Inc. (NYSE:MRK) has also dropped, falling 1.4% after the FDA expressed concerns about the side effects of the company's suvorexant insomnia drug.

WASHINGTON--Food and Drug Administration staff on Monday said a proposed sleep drug from Merck & Co. (MRK) is effective, but questioned the safety of the product's higher doses.

Merck & Co., Inc. Turning to the Dow, Merck & Co., Inc. (NYSE:MRK) was the worst performer, falling 1.7% after FDA reviewers questioned dosage levels in a new sleep aid drug.

Merck & Co., Inc. (NYSE:MRK) Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise physiology at University of Missouri.

Merck & Co., Inc. (NYSE:MRK) There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.